BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9782552)

  • 1. [Complementary medicine in health insurance. Economic analysis of the effects of including complementary procedures in health insurance. Project within the scope of the "Complementary Medicine" Research Program 34].
    Sommer JH; Bürgi M; Theiss R
    Schweiz Med Wochenschr Suppl; 1998; 102():1S-129S. PubMed ID: 9782552
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complementary medicine as political process. Swiss public opinion on the "Future with Complementary Medicine"].
    Rist L; Schwabl H
    Forsch Komplementmed; 2009 Apr; 16(2):76-8. PubMed ID: 19420952
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preventive medicine: costs and responsibilities of insurance companies].
    Brunner HH
    Praxis (Bern 1994); 1998 Jan; 87(3):57-60, 62-3. PubMed ID: 9492587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complementary medicine--health policy and health care costs].
    Jungi WF
    Praxis (Bern 1994); 1997 Oct; 86(41):1593-7. PubMed ID: 9417579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria and procedures for determining benefit packages in health care. A comparative perspective.
    Gress S; Niebuhr D; Rothgang H; Wasem J
    Health Policy; 2005 Jul; 73(1):78-91. PubMed ID: 15911059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The dilemma of effectiveness and economic value of alternative medicine].
    Marx HH
    Gesundheitswesen; 1997 May; 59(5):297-301. PubMed ID: 9289220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality management in complementary and integrative medicine.
    Witt CM; Berghoefer A
    Forsch Komplementmed; 2009 Jun; 16(3):190-4. PubMed ID: 19657204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usage of complementary therapies: information in light of the federal reimbursement policy].
    Crettaz von Roten F
    Rev Med Suisse; 2005 Jun; 1(26):1760. PubMed ID: 16117052
    [No Abstract]   [Full Text] [Related]  

  • 9. Complementary medicine.
    Zablocki E
    Healthplan; 1996; 37(4):36-8, 40-3. PubMed ID: 10162278
    [No Abstract]   [Full Text] [Related]  

  • 10. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No public funding for alternative care: survey.
    Rich P
    CMAJ; 2002 Jul; 167(1):70. PubMed ID: 12137095
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transurethral high energy microwave (thermo-) therapy of benign prostatic hyperplasia].
    Urologe A; 1998 Jan; 37(1):111-2. PubMed ID: 9540197
    [No Abstract]   [Full Text] [Related]  

  • 13. [Debatable borreliosis diagnosis. Patients stuck with the costs].
    Hakimi R
    MMW Fortschr Med; 2009 Jul; 151(30-33):7. PubMed ID: 19725176
    [No Abstract]   [Full Text] [Related]  

  • 14. [Public health structural reform and health insurance--corner stones of the German Society of Rehabilitation of Handicapped Persons].
    Rehabilitation (Stuttg); 1999 May; 38(2):127-30. PubMed ID: 10413804
    [No Abstract]   [Full Text] [Related]  

  • 15. [Success factors in hospital administration].
    Heberer M
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():926-37. PubMed ID: 9931755
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia].
    Jonas U; Melchior H; Rübben H
    Urologe A; 1998 Jan; 37(1):110-1. PubMed ID: 9540196
    [No Abstract]   [Full Text] [Related]  

  • 17. Complementary medicine: mainstream health care accommodates alternative therapies, wellness, and holistic health.
    Coile RC; Zipin M; Hofgard MW
    Russ Coiles Health Trends; 1998 Feb; 10(4):1, 3-9. PubMed ID: 10177965
    [No Abstract]   [Full Text] [Related]  

  • 18. Integration and reimbursement of complementary and alternative medicine by managed care and insurance providers: 2000 update and cohort analysis.
    Pelletier KR; Astin JA
    Altern Ther Health Med; 2002; 8(1):38-9, 42, 44 passim. PubMed ID: 11795621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is alternative medicine more cost-effective?
    Weeks J
    Med Econ; 2000 Mar; 77(6):139-42. PubMed ID: 10977200
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alternative therapy in fibromyalgia. Only expensive or "interpersonal medicine"?].
    Uhlemann C
    MMW Fortschr Med; 2002 Sep; 144(37):14. PubMed ID: 12380332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.